This just came out today. Biogen says it still hasn't decided what to do re: disclosure of PML cases in the future although they won't go back to the weekly update.

"This is new territory," Biogen spokeswoman Naomi Aoki said, adding that the company has always provided regulators with case-by-case updates as soon as information is available, while providing physicians and patients with the information needed to make treatment decisions.

"Obviously, we are a publicly traded company, so we have to make sure we are being appropriate for fair disclosure," she said.

Aoki said that Biogen is unlikely to provide weekly updates, as it did between January and July, but said that it hasn't decided on how to alter its policy in disclosing cases. It has held a number of conference calls and Webcasts with physicians in recent weeks to provide details and answer questions about the new cases.


I think the patients need fair disclosure too!

http://online.wsj.com/article/BT-CO-...11-716035.html